Oxytocin Research Dosage: Published Protocol Reference
Oxytocin dosage references vary by route and study context. The database lists Intravenous infusion: 0.5-6 mU/min (labor induction), Continuous titration during labor, Intramuscular: 10 IU, Single dose post-delivery, and Intranasal: 20-40 IU, Single dose or as directed. These are research-context references, not a universal protocol.
Direct Answer
Oxytocin (Pitocin/Syntocinon) is FDA-approved for obstetric indications with an extensive clinical record spanning decades. The evidence for its approved uses - labor induction and postpartum hemorrhage - is robust. Research into its prosocial, anxiolytic, and sexual health effects is active but Phase 2 level. For sexual health research involving trust, bonding, and social cognition, oxytocin is the most studied peptide candidate.
- Evidence grade
- Level A
- Research status
- FDA Approved
- Category
- Sexual Health
- Best for
- Labor induction (approved), postpartum hemorrhage prevention (approved), social bonding/prosocial behavior research, sexual function enhancement investigation
Research Dosage References
- <strong>Intravenous infusion</strong> - 0.5-6 mU/min (labor induction) - Continuous titration during labor - FDA-approved for labor induction. Requires continuous fetal and uterine monitoring. Dose increased by 1-2 mU/min every 15-60 minutes.
- <strong>Intramuscular</strong> - 10 IU - Single dose post-delivery - WHO-recommended for active management of third stage of labor and postpartum hemorrhage prevention.
- <strong>Intranasal</strong> - 20-40 IU - Single dose or as directed - Research route for social/behavioral studies. Also used for lactation support in some countries. Not FDA-approved for behavioral indications.
Half-Life
3-5 minutes (intravenous); longer effective duration with intranasal.
Evidence Limits
Dosage entries are compiled from labels, published studies, and research-context references where available. For Oxytocin, the evidence grade is Level A, and the current research status is FDA Approved.
Safety Signals
- Must be administered under medical supervision during labor
- Contraindicated in certain obstetric emergencies (cord prolapse, placenta previa, uterine rupture risk)
- Prolonged high-dose infusion can cause hyponatremia and water intoxication
- Not for elective induction without medical indication
Evidence Snapshot
| Evidence grade | Level A |
|---|---|
| Research status | FDA Approved |
| Best supported outcomes | Labor Induction & Augmentation (Level A), Postpartum Hemorrhage Prevention (Level A), Lactation Support (Level A), and Social Bonding & Trust (Level B) |
| Primary citation count | 3 |
| Last reviewed | 2026-04-04 |
Related Guides
How to Cite This Page
ExaminePeptides. "Oxytocin Research Dosage: Published Protocol Reference." Last reviewed 2026-04-04. https://examinepeptides.com/answers/oxytocin-research-dosage/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.